Ind-Swift Laboratories Ltd
Ind-Swift Laboratories Ltd - 532305 - Disclosures Under Regulation 29(2) Of The SEBI (Substantial Acquisition Of Shares And Takeover) Regulations, 2011
01 / The disclosure
What the company shared
Ind-Swift Laboratories Ltd - 532305 - Disclosures Under Regulation 29(2) Of The SEBI (Substantial Acquisition Of Shares And Takeover) Regulations, 2011
A question for your research
Check transaction size, funding, dilution, approvals and completion conditions before assessing the earnings impact.
Numbers found in document text 1 matches
Automatic text matches, not verified financial metrics. A match may come from a table heading or reporting year. Expand it to inspect the surrounding text and original page.
Rs. 10Page 2
Mchta, Annie Mehta, Bhanavi Melta, Divya Munjal, Ishav Mehta, Meenakshi Mehta, Neeta Munjal, Nidhi Munjal, Ravi Mehta, Sahil Munjal, Sunita Jain, Saurabh Munjal, Deepti Munjal & Daksh Mehta (hereinafter collectively referred to as "PACs") hereby inform your good office that the Acquirer, has acquired 14,00,000 (Fourteen Lakh) Equity Shares pursuant to the conversion of Fully Convertible Warrants having face value of Rs. 10/ each of the Target Company on October 08, 2026 into Equity Shares.
View source pageThe evidence
Read the source excerpts
01Subject: Disclosures under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011
Page 1
02Please find enclosed herewith disclosures received under Regulation 29(2) of SEBI (Substantial acquisition of Shares and Takeover) Regulations, 2011 received by the Company on 12th October, 2026 from Essix Biosciences Limited.
Page 1
03Tower, Dalal Street Bandra (East), Mumbai - 400051 Mumbai — 400001 Symbol: INDSWFTLAB Serip Code: 532305 Subject : Disclosure under Regulation 29(2) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
Page 2
04Dear Sir/Madam, With reference to the captioned subject, I, Himanshu Jain, Director on behalf of Essix Biosciences Limited ("Acquirer"), belonging to the Promoter and Promoter Group of Ind-Swift Laboratories Limited ("Target Company"), along with Gopal Munjal, Himanshu Jain, Navrattan Munjal, Rishav Mehta, S.R.
Page 2
05Mchta, Annie Mehta, Bhanavi Melta, Divya Munjal, Ishav Mehta, Meenakshi Mehta, Neeta Munjal, Nidhi Munjal, Ravi Mehta, Sahil Munjal, Sunita Jain, Saurabh Munjal, Deepti Munjal & Daksh Mehta (hereinafter collectively referred to as "PACs") hereby inform your good office that the Acquirer, has acquired 14,00,000 (Fourteen Lakh) Equity Shares pursuant to the conversion of Fully Convertible Warrants having face value of Rs. 10/ each of the Target Company on October 08, 2026 into Equity Shares.
Page 2
Source & verificationView the disclosure trail
- Summary method
- Exchange-provided text; no generated financial figures
- Exchange identifier
- 841f5876-7b53-4395-b171-05c04e38576a
- First collected
- 12 Oct 2026, 17:42 IST
- PDF extraction
- extracted · 2 pages read
- Extraction note
- Source excerpts; financial tables have not been validated.
- Document SHA-256
- e34054af65b48031956b545de0f6648b843c3e3ad7e4425eca4e23de6d1129b8